ArticleFrontiers in immunology2022

Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer.

Wenru Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.